 | | Vol. 14.00 – 15 January, 2025 |
| |
|
|
| The authors demonstrated that AGD1, derived from prostate CSCs, enhanced the stemness of prostate cancer cells and reduced the therapeutic effect of docetaxel in castration-resistant prostate cancer.
[Journal of Experimental & Clinical Cancer Research] |
|
|
|
 | | PUBLICATIONSListed by the impact factor of the journal |
|
|
|
| Investigators identified a cancer cell subpopulation termed stem/transient amplifying-like cells, which expressed genes associated with stem cell-like characteristics and metastatic potential.
[Cancer Letters] |
|
|
|
| Researchers identified a nicotine-triggered pathway regulating the stemness and tumorigenicity of intestinal stem cells and suggested the use of dibenzazepine as a potential therapeutic strategy for treating intestinal tumors.
[eLife] |
|
|
|
| Investigators increased expression of fibronectin type III and SPRY domain-containing 1 (FSD1) or interference with FSD1 phosphorylation reduces microtubule deacetylation, suppresses invasion of glioblastoma (GBM) stem cells, and ultimately mitigates tumor infiltration in orthotopic GBM xenografts.
[Science China Life Sciences] |
|
|
|
| Both musashi 2 (MSI2) and protein kinase D1 (PKD1) ameliorated short hairpin-long noncoding RNA FGD5 antisense RNA 1’s inhibition of hepatocellular carcinoma cell viability, proliferation, and stemness.
[Molecular Carcinogenesis] |
|
|
|
| Scientists elucidated Raddeanin A’s significant antitumor efficacy against glioblastoma in vitro and in vivo by targeting pathways linked to stemness and epithelial-mesenchymal transition, chiefly via the downregulation of S phase kinase-associated protein 2 (Skp2).
[Journal of Cancer] |
|
|
|
| Researchers investigated how arecoline-induced extracellular vesicle secretion suppresses PAX1 protein production through DNA hypermethylation and examined whether PAX1 downregulation enhances cancer stemness and immunosuppression in the tumor microenvironment.
[Oral Diseases] |
|
|
|
| Scientists suggested that targeting of glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) in colorectal cancer might contribute to a new therapeutic strategy that was based on suppression of Wnt signaling and epithelial-mesenchymal transition-related cancer progression driven by CSCs.
[Journal of Biochemistry] |
|
|
|
| Investigators explored the clinicopathological significance of MRPL24 in human cancers, with a particular focus on breast cancer.
[3 Biotech] |
|
|
|
|
| B-cell-specific Moloney murine leukemia virus insertion site-1 (Bmi-1) regulates self-renewal, proliferation, and differentiation of glioblastoma cells, promoting stemness and therapy resistance. The authors discuss the importance of targeting Bmi-1 which could be a promising therapeutic target for glioblastoma treatment.
[Cancer Medicine] |
|
|
|
|
| Eterna Therapeutics announced positive results from a preclinical study on the company’s lead cell therapy product, ERNA-101, which is designed to activate and regulate the immune system’s response to recognize and attack ovarian cancer cells.
[Eterna Therapeutics] |
|
|
|
|
| February 16-21, 2025
Pomona, California, United States |
|
|
|
|
|
| | Anglia Ruskin University – Cambridge, England, United Kingdom |
|
|
|
| | University of California San Francisco – San Francisco, California, United States |
|
|
|
| | University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| | IFOM ETS – The AIRC Institute of Molecular Oncology – Milan, Italy |
|
|
|
| | The University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
